Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
2.150
-0.070 (-3.15%)
At close: Aug 14, 2026, 4:00 PM EDT
2.165
+0.015 (0.68%)
After-hours: Aug 14, 2026, 7:59 PM EDT
Autolus Therapeutics Market Cap
Autolus Therapeutics has a market cap or net worth of $572.21 million as of August 14, 2026. Its market cap has increased by 16.85% in one year.
Market Cap
572.21M
Enterprise Value
370.58M
1-Year Change
16.85%
Ranking
Category
Stock Price
$2.15
ChartMarket Cap Chart
Since June 22, 2018, Autolus Therapeutics's market cap has decreased from $944.40M to $572.21M, a decrease of -39.41%. That is a compound annual growth rate of -5.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 572.20M | 8.04% |
| Dec 31, 2025 | 529.60M | -15.32% |
| Dec 31, 2024 | 625.40M | -44.19% |
| Dec 29, 2023 | 1.12B | 546.94% |
| Dec 30, 2022 | 173.20M | -54.23% |
| Dec 31, 2021 | 378.40M | -19.08% |
| Dec 31, 2020 | 467.60M | -21.25% |
| Dec 31, 2019 | 593.80M | -54.96% |
| Dec 31, 2018 | 1.32B | 39.60% |
| Jun 22, 2018 | 944.40M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eikon Therapeutics | 598.52M |
| Verastem | 595.91M |
| CorMedix | 587.70M |
| Arvinas | 586.51M |
| Altimmune | 571.88M |
| Prelude Therapeutics | 571.62M |
| ARS Pharmaceuticals | 561.88M |
| Artiva Biotherapeutics | 559.79M |